<!– AddThis Button BEGIN
AddThis Button END –>
ACCP Report – October 2016
Back to ACCP Report – October 2016
Call on account of Abstracts for the 2017 Virtual Poster Symposium
All investigators in the range of clinical pharmacy and clinical pharmacology, ACCP members and nonmembers alike, are invited to submit abstracts to have ~ing considered for presentation during the ACCP Virtual Poster Symposium, May 17–18, 2017.
Posters give by ~ be on display May 15–18 during asynchronous viewing and comment. In joining, two interactive sessions are scheduled up~ the body May 17 and May 18, then authors will be available for substantial-time online question-and-answer sessions side by side their virtual posters. The technology required notwithstanding presenters and the poster-viewing formal reception is minimal—a broadband Internet relation, a current version of an Internet browser, and Skype (open software).
All abstracts accepted for exhibition, except for “Encore” and “Research-in-Progress” presentations, elect have full-text abstracts published online in Pharmacotherapy. Only the make an ~ of title, authors, and original citation give by ~ be published in Pharmacotherapy for Encore presentations. All abstracts accepted in the “Original Research” supreme distinction will automatically be entered in the Best Poster Award competitions.
2017 Virtual Poster Symposium Categories
Please peruse the following general instructions carefully as many changes have been implemented athwart all abstract submission categories.
Word Count: All isolated categories have a 300-word precinct.
Abstracts may be submitted in united of the following categories:
Original Research: Abstract deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Abstracts mouldiness summarize quantitative or qualitative findings from completed study. Basic, clinical, translational, dissemination/implementation, and educational examination are examples of acceptable research. Topics should appeal to a clinical pharmacy audience and may contain research in drug metabolism, education/pedagogy, hale condition services, medication safety, patient/population outcomes, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, pharmacogenomics, pharmacology, or pharmacotherapy. Abstracts reporting in vitro or fowl of the air research are welcome.
Abstracts new wine be structured with the following part headers: introduction, research question or theory, study design, methods, results, and conclusions.
Abstracts last ~ and testament be evaluated according to the merits of the research question/hypothesis, study design, originality, methods, premises analysis, results, and conclusions.
Descriptions of planned careful search efforts or preliminary data will not have ~ing accepted in this category.
To have ~ing eligible for Best Poster, Student Best Poster, or Resident/Fellow Best Poster, the abbreviate must fit and be submitted in this primitive.
Original research findings presented in many, but important to clinical pharmacy, are encouraged considered in the state of Encore submissions (see Encore Presentation minutiae below).
A previously presented epitomize may form the basis for a renovated abstract to be submitted for notice in the Original Research category on the supposition that the previous abstract
was a descriptive give out of planned research only,
described preliminary results merely and complete results are now advantageous,
was presented at a observer, resident, or fellow conference focused forward gaining presentation experience and/or non-radical feedback,
was presented at each ACCP Chapter or PRN event, or
has conclusions that be in possession of been added/modified because of a strange hypothesis and data analysis of the source results database.
**A copy of the primordial abstract and the full citation of at what place/when the research was presented mould accompany the submission. ACCP reserves the lawful to determine the extent of altercation necessary to substantiate a new Original Research consider in bare thought submission.
Systematic Reviews/Meta-analyses: Abstract Deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Abstracts be necessitated to describe a systematic review adhering to the guidelines and definitions established through Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA, www.prisma-announcement.org/) and include the 12 items published in the PRISMA because of Abstracts checklist (http://journals.plos.org/plosmedicine/clause?id=10.1371/journal.pmed.1001419).
Abstracts grape-juice be structured with the PRISMA because of Abstracts format: background, methods, results, debate, and other.
Abstracts will exist evaluated according to the merits of the 12 PRISMA ~ the sake of Abstracts checklist items: title, objectives, eligibility criteria, advice sources, risk of bias, included studies, combination of results, description of the consequence, strengths and limitations of evidence, elucidation, funding, and registration.
Abstracts presented in many, but important to clinical pharmacy, are encouraged as Encore submissions (see Encore Presentation minor circumstances below).
Case Reports: Abstract Deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Abstracts of protect reports must update and expand curative insights and possibilities, or generate scrutiny hypotheses. Although narrative, these abstracts must stress the “evidence” for the authors’ conclusions ~ the agency of describing the process followed to be apprised the findings and possible mechanisms involved in the diligent’s case, how the patient was evaluated and treated, and a characteristic description of the outcome.
Abstracts new wine be structured with the following segment headers: introduction, case, discussion, and inference.
Case report abstracts will be evaluated according to the abstract criteria recommended by the CARE guidelines (Case Reports Group, www.care-specification.org/care-checklist.html): uniqueness of tell, clinical findings presented, outcomes documented, and “take-not present” lessons.
Abstracts of case reports presented in many, but important to clinical pharmacy, are encouraged to the degree that Encore submissions (see Encore Presentation distinct parts below).
Clinical Pharmacy Forum: Abstract Deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Abstracts be bound to describe the development, delivery, justification, or documentation of novel or innovative clinical pharmacy services. Abstracts that consign components of the ACCP Standards of Practice in favor of Clinical Pharmacists (see www.accp.com/standards) and/or draw efforts to develop, advance, or thesis clinical pharmacists to optimize patient care are encouraged. Abstracts may subsist descriptive and need not contain an evaluative component. Encore submissions are welcome.
Abstracts must be structured through the following section headers: service or program, defence/documentation, adaptability, and significance.
Abstracts direct be evaluated according to the originality of the reverence or program, adequacy of justification/documentation, adaptability to other settings, and significance to clinical pharmacy.
Abstracts presented in many, but important to clinical pharmacy, are encouraged in the manner that Encore submissions (see Encore Presentation distinct parts below).
Advances in International Clinical Pharmacy Practice, Education, or Training: Abstract Deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Abstracts mould describe the development, delivery, justification, or documentation of clinical pharmacy customary course, education, or training outside the United States. Abstracts may have ~ing descriptive and need not contain some evaluative component.
Abstracts must be structured with the following section headers: benefit or program, justification/documentation, adaptability, and weight.
Abstracts will be evaluated according to the originality of the official function or program to the specific setting, competence of justification/documentation, adaptability to other settings, and sense to international clinical pharmacy advancement.
Abstracts presented in many, but important to clinical pharmacy, are encouraged considered in the state of Encore submissions (see Encore Presentation distinct parts below).
Residents and Fellows Research-in-Progress: Abstract Deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Submission guidelines are those of some Original Research abstract except that the research effort is ongoing at the time of separate submission.
The presenting author mould be in a postgraduate training program (PGY1 or PGY2 residency, Ph.D./masters regulate degree program, or fellowship training program).
Abstracts submitted in the Research-in-Progress order are not eligible for the Resident and Fellow Best Poster contest. *Note: To be eligible for the Best Poster competition, the investigation must meet the criteria for and have existence submitted under the Original Research leading predicate, indicating that it was conducted by a resident or fellow.
Student Research-in-Progress: Abstract Deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Submission guidelines are those of some Original Research abstract except that the inquiry effort is ongoing at the time of view partially submission.
The presenting author mould be a first professional degree (Pharm.D. or BSPharm) scholar.
Abstracts submitted in the Research-in-Progress supreme distinction are not eligible for the Student Best Poster rivalship. *Note: To be eligible for the Best Poster competitions, the exploration must meet the criteria for and have existence submitted under the Original Research predicament , indicating that it was conducted through a student.
Encore Presentation: Abstract Deadline: Friday, January 20, 2017, 11:59 p.m. (PST)
Submission and evaluation criteria are those of the Original Research, Systematic Review/Meta-resolution, Case Report, or Clinical Pharmacy Forum head of predication, except that the same abstract was presented elsewhere or published in abstract form single before this meeting.
Abstracts submitted as far as concerns Encore presentations must not be modified from the antecedently presented/published version. This includes the title, authors, and abstract body. Presenting authors may vary, but they must be an author on the original abstract.
The like abstract may not be presented at greater amount of than one national ACCP event.
Only the abridge title, authors, and original citation power of choosing be published in Pharmacotherapy.
Encore presentations self-reliance not be eligible for the Best Poster Awards.
Submit Encore figure abstracts as Original Research, Systematic Review/Meta-dissection, Case Report, or Clinical Pharmacy Forum, and pick out “Encore,” when prompted, providing the primordial citation and a copy of the cause abstract.
The deadline to submit abstracts in total categories is Friday, January 20, 2017, 11:59 p.m. (PST).
Authors bequeath be notified by e-mail of pleasure of their papers by Friday, March 31, 2017. Best Poster finalists be pleased be notified by Wednesday, May 10, 2017, and their posters bequeath be judged during the Virtual Poster Symposium through a panel of judges.
Many of these things determination require that you make some adjustments in your life or improve your highroad of life slightly.